A study to assess the safety, tolerability, and pharmacokinetics of AZD9550 following single ascending dose administration to healthy participants

Trial Identifier:	D8460C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	May 2023
Primary Completion Date:	November 2023
Study Completion Date:	November 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.